NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis-Reference-Cited by-同舟云学术

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

Published:2015 Issue:5 Volume:38 Page:221-229
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Kurbacher Christian M.,Fietz Thomas,Diel Ingo J.,Egert Matthias,Hurtz Hans-Jürgen,Lück Andreas,Weide Rudolf,Salat Christoph,Wolff Thomas,Zaiss Matthias,Klare Peter,Losem Christoph,Illmer Thomas,Weißenborn Georg,Steffens Claus-Christoph,Schulze Matthias,Tesch Hans,Oskay-Oezcelik Gülten,Teichmann Beate,Harde Johanna,Scheuerlein Robert Willy

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany;Supportive Care in Cancer;2022-09-08

2. Prophylactic administration of mecapegfilgrastim after chemotherapy in patients with lymphoma;Annals of Palliative Medicine;2021-12

3. Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study;Annals of Translational Medicine;2021-05

4. Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting;Anticancer Research;2021-01

5. Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review;Critical Reviews in Oncology/Hematology;2021-01